Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Cancer gene therapy.Technol Cancer Res Treat. 2005; 4: 315-330
- Gene therapy for cancer treatment: past, present and future.Clin Med Res. 2006; 4: 218-227
- Gene therapy returns to centre stage.Nature. 2015; 526: 351-360
- Vector engineering, strategies and targets in cancer gene therapy.Cancer Gene Ther. 2021; https://doi.org/10.1038/s41417-021-00331-7
- Cancer gene therapy: an awkward adolescence.Cancer Gene Ther. 2003; 10: 501-508
- Advances in adenovirus-mediated p53 cancer gene therapy.Expert Opin Biol Ther. 2013; 13: 1569-1583
- Gene therapy for lung cancer.Crit Rev Oncog. 2016; 21: 115-124
- Mutated p53 in HGSC- from a common mutation to a target for therapy.Cancers (Basel). 2021; 13: 3465
- Mutational landscape and environmental effects in bladder cancer.Int J Mol Sci. 2020; 21: 6072
- The role of p53 dysfunction in colorectal cancer and its implication for therapy.Cancers (Basel). 2021; 13: 2296
- Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth.Gene Ther. 2020; 27: 15-26
- Vaccine strategies to improve anti-cancer cellular immune responses.Front Immunol. 2019; 10: 8
- An introduction to immunology and immunopathology.Allergy Asthma Clin Immunol. 2018; 14: 49
- Protein-based nanoparticles in cancer vaccine development.Nanomedicine. 2019; 15: 164-174
- Cancer vaccines: a brief overview.Methods Mol Biol. 2016; 1403: 755-761
- Sipuleucel-T immunotherapy for castration-resistant prostate cancer.N Engl J Med. 2010; 363: 411-422
- Oncolytic virus therapy: a new era of cancer treatment at dawn.Cancer Sci. 2016; 107: 1373-1379
- Experimental therapy of human glioma by means of a genetically engineered virus mutant.Science. 1991; 252: 854-856
- Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) production.Microbes Infect. 2011; 13: 291-302
- Recent advances of oncolytic virus in cancer therapy.Hum Vaccin Immunother. 2020; 16: 2389-2402
- A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.Clin Cancer Res. 2006; 12: 6737-6747
- Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpes virus in patients with unresectable metastatic melanoma.J Clin Oncol. 2009; 27: 5763-5771
- Talimogene Laherparepvec improves durable response rate in patients with advanced melanoma.J Clin Oncol. 2015; 33: 2780-2788
- Entering the modern era of gene therapy.Annu Rev Med. 2019; 70: 273-288
- Chimeric antigen receptor (CAR) T cells: lessons learned from targeting of CD19 in B cell malignancies.Drugs. 2017; 77: 237-245
- Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia.N Engl J Med. 2018; 378: 439-448
- Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma.N Engl J Med. 2017; 377: 2531-2544
- Cell toxicity: current management and future directions.Hemasphere. 2019; 3: e186
- CRISPR/Cas9 gene-editing: research technologies, clinical applications and ethical considerations.Semin Perinatol. 2018; 42: 487-500
- CRISPR-Cas9 for cancer therapy: opportunities and challenges.Cancer Lett. 2019; 447: 48-55
- Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.J Virol. 2014; 88: 11965-11972
- In Vitro and In vivo synergistic therapeutic effect of cisplatin with human papillomavirus16 E6/E7 CRISPR/Cas9 on cervical cancer cell line.Transl Oncol. 2016; 9: 498-504
- Adjuvant pembrolizumab versus placebo in resected stage III melanoma.N Engl J Med. 2018; 378: 1789-1801
- Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma.N Engl J Med. 2021; 385: 683-694
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
